Intraoperative cell-salvaged autologous blood transfusion is safe in metastatic spine tumour surgery: early outcomes of prospective clinical study

[1]  T. Jahng,et al.  Clinical Efficacy of Intra-Operative Cell Salvage System in Major Spinal Deformity Surgery , 2018, Journal of Korean Neurosurgical Society.

[2]  N. Lawrentschuk,et al.  Intra‐operative cell salvage in urological surgery: a systematic review and meta‐analysis of comparative studies , 2018, BJU international.

[3]  D. Sciubba,et al.  Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence. , 2018, Annals of translational medicine.

[4]  A. Zaw,et al.  Metastatic spine tumor surgery: does perioperative blood transfusion influence postoperative complications? , 2017, Transfusion.

[5]  C. Lim,et al.  Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture? , 2017, Transfusion medicine.

[6]  A. Zaw,et al.  Evolution in treatment strategy for metastatic spine disease: Presently evolving modalities. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  Allan R. Martin,et al.  Symptomatic spinal metastasis: A systematic literature review of the preoperative prognostic factors for survival, neurological, functional and quality of life in surgically treated patients and methodological recommendations for prognostic studies , 2017, PloS one.

[8]  A. Zaw,et al.  Perioperative blood transfusion: does it influence survival and cancer progression in metastatic spine tumor surgery? , 2017, Transfusion.

[9]  J. Stephenson,et al.  The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. , 2016, The spine journal : official journal of the North American Spine Society.

[10]  A. Zaw,et al.  Is Autologous Salvaged Blood a Viable Option for Patient Blood Management in Oncologic Surgery? , 2017, Transfusion medicine reviews.

[11]  C. Lim,et al.  Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells , 2016, European Spine Journal.

[12]  Aye Sandar Zaw Mph,et al.  Blood Loss and Transfusion Requirements in Metastatic Spinal Tumor Surgery: Evaluation of Influencing Factors , 2016, Annals of Surgical Oncology.

[13]  H. Wong,et al.  Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery? , 2016, European Spine Journal.

[14]  Zheng Li,et al.  Does intraoperative cell salvage system effectively decrease the need for allogeneic transfusions in scoliotic patients undergoing posterior spinal fusion? A prospective randomized study , 2015, European Spine Journal.

[15]  A. Zaw,et al.  Flow Cytometric Evaluation of the Safety of Intraoperative Salvaged Blood Filtered with Leucocyte Depletion Filter in Spine Tumour Surgery , 2014, Annals of Surgical Oncology.

[16]  Naresh Kumar Frcs,et al.  Can There be a Place for Intraoperative Salvaged Blood in Spine Tumor Surgery? , 2014, Annals of Surgical Oncology.

[17]  H. Gakhar,et al.  Role of Intraoperative Red Cell Salvage and Autologus Transfusion in Metastatic Spine Surgery: A Pilot Study and Review of Literature , 2013, Asian spine journal.

[18]  J. Joh,et al.  Long‐term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[19]  K. McMasters,et al.  Phase II Comparison Study of Intraoperative Autotransfusion for Major Oncologic Procedures , 2011, Annals of Surgical Oncology.

[20]  J. Bloem,et al.  RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline , 2009, European Radiology.

[21]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[22]  S. Catling,et al.  Use of a leucocyte filter to remove tumour cells from intra‐operative cell salvage blood , 2008, Anaesthesia.

[23]  H. Matsuzaki,et al.  A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor Prognosis , 2005 .

[24]  D. Deheinzelin,et al.  Molecular evidence of tumour cell removal from salvaged blood after irradiation and leucocyte depletion , 2004 .

[25]  D Machin,et al.  Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches , 2001, Statistics in medicine.

[26]  K. Tomita,et al.  Surgical Strategy for Spinal Metastases , 2001, Spine.

[27]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[28]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.